ESH / ESC Guidelines for the management of arterial hypertension

By M. Tendera, M. D. Buyzere, S. Erdine, Christian Funck Brentano, V. Gerc, G. Germanò, S. Gielen, A. W. Hoes, J. Jordan, D. Lovic and 13 more. 2013

1,850 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/245710674fb58c6f4095692f6af0372b0a174b53

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Umemura
2. H. Arima
3. Shuji Arima
4. K. Asayama
5. T. Ohkubo
6. K. Matsumura
7. S. Ito
8. H. Uzun

Citations in the corpus

• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, methodology): “Indications for the use of β-blockers are hypertension in young patients showing sympathetic hyperactivity, effort angina, after myocardial infarction, hypertension complicated by tachycardia, hypertension with a high cardiac output, including that caused by hyperthyroidism, high renin hypertension ”
• Endothelial Dysfunction and Hypertension. (2016, background): “Despite the difficulty of distinguishing the possible direct effects of antihypertensive drugs on endothelial function from indirect protection secondary to the decreased blood pressure, the effects of various antihypertensive drugs on endothelial dysfunction have been tested (Mancia et al. 2013).”